Evidence map›Paper›PMID 40540177›Full record

ReviewMolecular neurobiology2025

A New Insight in Cellular and Molecular Signaling Regulation for Neural Differentiation Program.

Rabia Shahid, Sumreen Begum

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rabia ShahidSindh Institute of Urology and Transplantation (SIUT), Near Civil Hospital, Sardar Yaqoob Ali Khan Road, Karachi, 74200, Pakistan.
Sumreen BegumSindh Institute of Urology and Transplantation (SIUT), Near Civil Hospital, Sardar Yaqoob Ali Khan Road, Karachi, 74200, Pakistan. sumreenbegum@gmail.com.ORCID http://orcid.org/0000-0002-2236-1726

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous neurological conditions impact the brain, spinal cord, and nerves, including neurodegenerative diseases such as Alzheimer's and Parkinson's disease, autoimmune disorders like Multiple sclerosis, seizure disorders such as Epilepsy, and neuropsychiatric disorders like Schizophrenia and Autism spectrum disorders. Neural stem cells (NSCs) exhibit developmental abnormalities linked to the dysregulation of signaling pathways associated with diverse neurological disorders. NSCs can self-renew and differentiate into various neural cell types. NSC holds enormous therapeutic potential for targeting anomalous neural networks, traumatic brain injuries, and stroke. NSC differentiation programs are regulated by multiple elements, comprising growth factors, neurotransmitters, and extracellular matrix components, with intricate orchestration of cellular and molecular signaling pathways. This review aims to provide current information regarding the critical mechanisms of neural signaling circuits with interacting proteins involved in regular neural differentiation programs. The pivotal complex communication channels include the Notch, Wnt, BMP, RA, FGF, EGF, and Hippo signaling pathways. These circuits are implicated in the processes of NSC maintenance, proliferation, and differentiation, which collectively govern neural fate determination. This information can be used to initiate and promote neural regeneration. Based on the contributing factors in each signaling pathway, novel methods can be formulated and implemented for better and more robust neural differentiation programs. Hence, innovative approaches to treating neural disorders through an enhanced understanding of neural differentiation signaling pathways are paving the way for more effective therapeutic strategies.

Indexed as

Cell DifferentiationNeural Stem CellsNeurogenesisNeuronsSignal TransductionAnimalsHumansAlzheimer’s diseasesAutismEGFFGFFrizzledHippoMitogen-activated protein kinaseNeuronalNotchRetinoic acidSingle-cell sequencingTherapeutics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.